HEALTH4CLL2: a Randomized Waitlist Control Trial of Behavioral Interventions in Patients with Chronic Lymphocytic Leukemia

Description

To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.

Conditions

Chronic Lymphocytic Leukemia

Talk to us

Study Overview

On this page

Study Details

Study overview

To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.

HEALTH4CLL2: a Randomized Waitlist Control Trial of Behavioral Interventions in Patients with Chronic Lymphocytic Leukemia

HEALTH4CLL2: a Randomized Waitlist Control Trial of Behavioral Interventions in Patients with Chronic Lymphocytic Leukemia

Condition
Chronic Lymphocytic Leukemia
Intervention / Treatment

-

Contacts and Locations

Houston

M D Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults age 18-85 years of age with a histologically confirmed diagnosis of CLL and the ability to provide signed informed consent.
  • * Self-reported physical activity will be assessed prior to enrollment and patients with a physical activity level below the level prescribed in our study will be eligible for inclusion.
  • * Other active malignancy within 1 year of study enrollment (excluding non-melanoma skin cancer)
  • * Richter's transformation, another medical condition which would prevent safe participation in the behavioral intervention
  • * Major surgery within 1 month of enrollment
  • * Non-English speakers
  • * Cognitively impaired adults
  • * Pregnancy.

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Alessandra Ferrajoli, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2025-07-03